Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus ropivacaine + dexmedetomidine for post-thoracotomy pain
IRCT20190107042264N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ropivacaine and dexmedetomidine in post-thoracotomy pain syndrome (PTPS) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Post operative Pain. Started Oct 2020; status: completed.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
post-thoracotomy pain syndrome (PTPS)
Beyond the preview
Go deeper on IRCT20190107042264N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190107042264N2.